WordNet

the 3rd letter of the Roman alphabet (同)c
(music) the keynote of the scale of C major
a general-purpose programing language closely associated with the UNIX operating system
(physics) the transfer of energy between elementary particles or between an elementary particle and a field or between fields; mediated by gauge bosons (同)fundamental interaction
a mutual or reciprocal action; interacting

PrepTutorEJDIC

《所有・所属》…『の』,…のものである,…に属する・《材料・要素》…『でできた』,から成る・《部分》…『の』[『中の』] ・《数量・単位・種類を表す名詞に付いて》…の・《原因・動機》…『で』,のために(because of) ・《主格関係》…『の』,による,によって・《目的格関係》…『を』,の・《同格関係》…『という』・《関係・関連》…『についての』[『の』],の点で・《抽象名詞などと共に》…の[性質をもつ] ・《『It is』+『形』+『of』+『名』+『to』 doの形で,ofの後の名詞を意味上の主語として》・《分離》…『から』・《起原・出所》…『から』[『の』](out of) ・《『名』+『of』+『a』(『an』)+『名』の形で》…のような・《『名』+『of』+『mine』(『yours, his』など独立所有格)の形で》…の…・《時》(1)《副詞句を作って》…に《形容詞句を作って》…の・《時刻》《米》…前(to,《米》before)
carbonの化学記号
(…との)相互作用《+『between』(『with』)+『名』》
OLD French古[代]フランス語

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. アゾールの薬理学 pharmacology of azoles
2. 肺移植後の免疫抑制の維持 maintenance immunosuppression following lung transplantation
3. リファマイシン（リファンピン、リファブチン、リファペンチン） rifamycins rifampin rifabutin rifapentine
4. 第1世代抗精神病剤：薬理学、投与、および副作用の比較 first generation antipsychotic medications pharmacology administration and comparative side effects
5. 心臓移植における免疫抑制療法の導入および維持 induction and maintenance of immunosuppressive therapy in cardiac transplantation

Inhibition of human cytochrome P450 isoenzymes by a phenothiazine neuroleptic levomepromazine: An in vitro study.

Basińska-Ziobroń A1, Daniel WA1, Wójcikowski J2.
Pharmacological reports : PR.Pharmacol Rep.2015 Dec;67(6):1178-82. doi: 10.1016/j.pharep.2015.04.005. Epub 2015 Apr 23.
BACKGROUND: Inhibition of cytochrome P450 (CYP) isoenzymes is the most common cause of harmful drug-drug interactions. The present study was aimed at examining the inhibitory effect of the phenothiazine neuroleptic levomepromazine on main CYP isoenzymes in human liver.METHODS: The experiment was per
PMID 26481538

Toxicokinetics of lefetamine and derived diphenylethylamine designer drugs-Contribution of human cytochrome P450 isozymes to their main phase I metabolic steps.

Wink CS1, Meyer GM1, Meyer MR1, Maurer HH2.
Toxicology letters.Toxicol Lett.2015 Nov 4;238(3):39-44. doi: 10.1016/j.toxlet.2015.08.012. Epub 2015 Aug 11.
Lefetamine was first marketed in the 1940s as an opioid analgesic. Since withdrawal symptoms were observed during treatment, it became a controlled substance. Its N-ethyl and N-iso-propyl derivatives appeared on the illicit drug market in 2008. Metabolism studies for lefetamine and these derivatives
PMID 26276083